KLA CORPORATION vs Waters Corporation, two Scientific Instruments stocks. A side-by-side on valuation, growth, margins, returns, and what each price is betting.
Where KLAC and WAT diverge most: on ev/ebitda, KLAC reads 2523.1 and WAT reads 55.0; on return on equity, KLAC reads 80.1% and WAT reads 3.0%. The rest of the comparable metrics sit closer together. What KLAC's price implies is a bet that sits within the historical range (whole-company basis). The bull and bear cases for each are in their full reports below.
| Metric | KLAC | WAT |
|---|---|---|
| Price | $182.68 | $377.25 |
| Market cap | $240.7B | $31.0B |
| Sector | Scientific Instruments | Scientific Instruments |
| Stage | Growth | Growth |
| P/E | 51.7 | 47.8 |
| P/B | 41.28 | 2.03 |
| P/S | 18.38 | 8.16 |
| EV/EBITDA | 2523.1 | 55.0 |
| Revenue growth | +13.8% | +28.6% |
| Operating margin | — | -3.7% |
| Net margin | 35.7% | 11.9% |
| Return on equity | 80.1% | 3.0% |
| Return on assets | 27.7% | 1.8% |
| Return on invested capital | — | 2.4% |
| FCF yield | 1.7% | 1.1% |
| Dividend yield | 0.4% | — |
| Debt / equity | 1.01 | 0.32 |
| Current ratio | 3.03 | 1.79 |
| Altman Z (solvency) | 7.58 | 2.84 |
| Piotroski F (quality) | 7 / 9 | 4 / 9 |
Each week boothcheck ranks the stocks whose prices are betting on the most. Read the most stretched bets archive →
boothcheck is also on Android. Get the app on Google Play →
The stronger value is highlighted per metric where one is strictly better on that single number; it is not an overall verdict on either company. For informational and research purposes only. Not investment advice. Not a recommendation to buy, sell, or hold any security. boothcheck is not a registered investment adviser. Past performance does not guarantee future results.